A new drug is transforming the lives of children born with a severe form of epilepsy, say doctors and families. Dravet syndrome can cause dozens of dangerous seizures a day and affects about one in ...
A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy.
A new experimental treatment for children with a hard-to-treat form of epilepsy is safe and can reduce seizures dramatically, helping them lead much healthier and happier lives, the findings of a UCL ...
The first gene-regulating treatment for epilepsy achieves promising results in an initial trial with 81 patients ...
A Phase I/IIa clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that ...
Disclaimer: This is sponsored content. All opinions and views are of the advertiser and do not reflect the same of Fox 17. Epilepsy is a neurological condition that causes seizures due to ...
Please provide your email address to receive an email when new articles are posted on . ORLANDO — Although effective treatments have been established for those with epilepsy, there is a need for more ...
Longitudinal data suggested that treatment-resistant focal epilepsy may improve over time. Nearly 70% had reduced seizure frequency and some patients achieved seizure freedom. Improvement was not ...
Biopharmaceutical researchers are working to create a future where patients get the right medicines the first time. According to the Epilepsy Foundation, one-third of people with epilepsy live with ...
What is it like to go between practicing medicine and working at a startup? Dr. Martha Morrell, NeuroPace’s CMO, discusses the transition and dives into three-year effectiveness data from the ...
A surgical treatment commonly used to reduce epileptic seizures in adults also is effective and safe for children, according to a new study. The study is one of the first to investigate responsive ...
A prominent epileptologist and neurologist, Prof. Patrick Adjei, who said this, pointed out that stigma had been one of the main drivers of the high treatment gap of the condition, urging that nobody ...